Package 0591-3331-19

{"route": ["ORAL"], "spl_id": "08ef0752-1fcf-418b-9b72-3fbab8b23058", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["a1e768fd-c28f-4b49-822d-ccc315b4099c"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-05)", "package_ndc": "0591-3331-05", "marketing_start_date": "20081126"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-19)", "package_ndc": "0591-3331-19", "marketing_start_date": "20081126"}, {"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3331-30)", "package_ndc": "0591-3331-30", "marketing_start_date": "20081126"}], "brand_name": "Bupropion Hydrochloride XL", "product_id": "0591-3331_08ef0752-1fcf-418b-9b72-3fbab8b23058", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0591-3331", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "XL", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA077715", "marketing_category": "ANDA", "marketing_start_date": "20081126", "listing_expiration_date": "20271231"}